Literature DB >> 17479418

Two ellagic acid glycosides from Gleditsia sinensis Lam. with antifungal activity on Magnaporthe grisea.

Ligang Zhou1, Duan Li, Weibo Jiang, Zhizhong Qin, Shuang Zhao, Minghua Qiu, Jianyong Wu.   

Abstract

Two ellagic acid glycosides were isolated by bioassay-guided fractionation from the antimicrobial ethyl acetate fraction of the ethanol extract from Gleditsia sinensis spines, and identified as 3-O-methylellagic acid-4'-(5''-acetyl)-alpha-L-arabinofuranoside (1) and 3-O-methylellagic acid-4'-O-alpha-L-rhamnopyranoside (2). Both compounds were isolated from this plant species for the first time, and 1 is a new compound. The two compounds showed significant antifungal activity against the spore germination of rice blast fungus Magnaporthe grisea, with an IC(50) value of 13.56 microg mL(-1) for 1 and 16.14 microg mL(-1) for 2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479418     DOI: 10.1080/14786410701192702

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  4 in total

1.  Inhibitory activities against rice pathogens of 8-hydroxy-2,4,6-octatriynamide from Agrocybe sp.

Authors:  Yongbiao Zheng; Xiaoping Xu; Yabin Wu
Journal:  World J Microbiol Biotechnol       Date:  2016-02-09       Impact factor: 3.312

Review 2.  From Traditional Usage to Pharmacological Evidence: A Systematic Mini-Review of Spina Gleditsiae.

Authors:  Jiayu Gao; Xiao Yang; Weiping Yin
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-28       Impact factor: 2.629

3.  Antifungal activity of the essential oil of Illicium verum fruit and its main component trans-anethole.

Authors:  Yongfu Huang; Jianglin Zhao; Ligang Zhou; Jihua Wang; Youwen Gong; Xujun Chen; Zejian Guo; Qi Wang; Weibo Jiang
Journal:  Molecules       Date:  2010-10-27       Impact factor: 4.411

4.  Ethanol extract of Gleditsia sinensis thorn suppresses angiogenesis in vitro and in vivo.

Authors:  Jin-Mu Yi; Jong-Shik Park; Se-Mi Oh; Jun Lee; Jinhee Kim; Dal-Seok Oh; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2012-12-04       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.